Publications by authors named "Philip Connell"

Claim this Profile
Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.
Rohan R Katipally, Liam F Spurr, Stanley I Gutiontov, William Tyler Turchan, Philip Connell

JCO Precis Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Team Approach: Management of Pathologic Fractures.
Aws Hammad, Osman Ahmed, Philip P Connell, Daniel Olson, Tessa Balach

JBJS Rev· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy.
Liam F Spurr, Carlos A Martinez, Rohan R Katipally, Soumya C Iyer, Sian A Pugh, Philip P Connell

NPJ Precis Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncanonical NF-κB factor p100/p52 regulates homologous recombination and modulates sensitivity to DNA-damaging therapy.
Brian Budke, Alison Zhong, Katherine Sullivan, Chanyoung Park, David I Gittin, Philip P Connell

Nucleic Acids Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer.
Ke Zuo, Xiaoying Yuan, Xizi Liang, Xiangjie Sun, Shujin Liu, Philip P Connell

Breast Cancer Res Treat· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of distinctive mismatch tolerance between Rad51 and Dmc1 in homologous recombination.
Jingfei Xu, Lingyun Zhao, Sijia Peng, Huiying Chu, Rui Liang, Philip P Connell

Nucleic Acids Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.
Stanley I Gutiontov, William Tyler Turchan, Liam F Spurr, Sherin J Rouhani, Carolina Soto Chervin, Philip P Connell

Sci Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-Induced Sarcoma After Heterotopic Ossification Prophylaxis: A Case Report.
David M Rosenberg, Benjamin Onderdonk, Nasma K Majeed, Grace Guzman, Yasser Farid, Philip P Connell

JBJS Case Connect· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Radiation Therapy Toxicity in the Setting of Germline PTEN Mutation.
Ken Tatebe, Steven J Chmura, Philip P Connell

Pract Radiat Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart V5 predicts cardiac events in unresectable lung cancer patients undergoing chemoradiation.
Lisa Ni, Matthew Koshy, Philip Connell, Sean Pitroda, Daniel W Golden

J Thorac Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Drug Candidates That Inhibit the D-Loop Activity of RAD51.
Brian Budke, Werner Tueckmantel, Kelsey Miles, Alan P Kozikowski, Philip P Connell

ChemMedChem· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.
Alexandre Chlenski, Chanyoung Park, Marija Dobratic, Helen R Salwen, Brian Budke, Philip P Connell

Mol Cancer Ther· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retuning the Radio in Radiobiology.
Steven J Chmura, Philip P Connell, Ralph R Weichselbaum

J Natl Cancer Inst· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy.
Adil S Akthar, Matthew Koshy, Mark K Ferguson, Septimiu Murgu, D Kyle Hogarth, Philip P Connell

Clin Lung Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer.
Sean P Pitroda, Riyue Bao, Jorge Andrade, Ralph R Weichselbaum, Philip P Connell

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?
Brian Budke, Wei Lv, Alan P Kozikowski, Philip P Connell

ChemMedChem· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51.
Wei Lv, Brian Budke, Michal Pawlowski, Philip P Connell, Alan P Kozikowski

J Med Chem· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies to Overcome Late Complications from Radiotherapy for Childhood Head and Neck Cancers.
Michael T Spiotto, Philip P Connell

Oral Maxillofac Surg Clin North Am· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual and Opposite Effects of hRAD51 Chemical Modulation on HIV-1 Integration.
Sylvain Thierry, Mohamed Salah Benleulmi, Ludivine Sinzelle, Eloise Thierry, Christina Calmels, Philip Connell

Chem Biol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells.
Jennifer M Mason, Kritika Dusad, William Douglass Wright, Jennifer Grubb, Brian Budke, Philip P Connell

Nucleic Acids Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors.
Jennifer M Mason, Hillary L Logan, Brian Budke, Megan Wu, Michal Pawlowski, Philip P Connell

Cancer Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy.
Sean P Pitroda, Itai M Pashtan, Hillary L Logan, Brian Budke, Thomas E Darga, Philip P Connell

Sci Transl Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule derived from a natural product that mitigates radiation injury.
Philip P Connell, Ralph R Weichselbaum

Proc Natl Acad Sci U S A· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time solution measurement of RAD51- and RecA-mediated strand assimilation without background annealing.
Brian Budke, Yuen-Ling Chan, Douglas K Bishop, Philip P Connell

Nucleic Acids Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New paradigms and future challenges in radiation oncology: an update of biological targets and technology.
Stanley L Liauw, Philip P Connell, Ralph R Weichselbaum

Sci Transl Med· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis